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Animal experiments have shown that nonhuman primates, cats, ferrets, hamsters, rabbits, and bats can
be infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition, SARS-CoV-2 RNA
has been detected in felids, mink, and dogs in the field. Here, we describe an in-depth investigation
using whole-genome sequencing of outbreaks on 16 mink farms and the humans living or working on
these farms. We conclude that the virus was initially introduced by humans and has since evolved, most
likely reflecting widespread circulation among mink in the beginning of the infection period, several
weeks before detection. Despite enhanced biosecurity, early warning surveillance, and immediate culling of
animals in affected farms, transmission occurred between mink farms in three large transmission
clusters with unknown modes of transmission. Of the tested mink farm residents, employees, and/or
individuals with whom they had been in contact, 68% had evidence of SARS-CoV-2 infection.
Individuals for which whole genomes were available were shown to have been infected with strains
with an animal sequence signature, providing evidence of animal-to-human transmission of
SARS-CoV-2 within mink farms.
I
n late December 2019, severe acute res-
piratory syndrome coronavirus 2 (SARS-
CoV-2) was identified as the cause of a
viral pneumonia outbreak, possibly rel-
ated to a seafood and live animal market
inWuhan, China (1). Since then, SARS-CoV-2
has spread across the world. By 8 October 2020,
more than 36.1 million people had been in-
fected with SARS-CoV-2, resulting in more
than 1 million deaths (2). In the Netherlands,
more than 155,000 infections have been con-
firmed, more than 6500 SARS-CoV-2–related
deaths have been reported, and nonpharma-
ceutical interventions have been put into place
to prevent further spread of SARS-CoV-2 (3).
In view of the similarities of the new virus
and SARS-CoV-1, a zoonotic origin of the out-
break was suspected and linked to a Wuhan
freshmarketwhere various animals—including
fish, shellfish, poultry, wild birds, and exotic
animals—were sold. However, other cases with
onset well before the period correlated with
the Wuhan market–associated cluster were
observed, which suggests the possibility of
other sources (4). Although closely related co-
ronaviruses found in bats (5, 6) and pangolins
(7, 8) have the greatest sequence identity to
SARS-CoV-2, the most likely divergence of
SARS-CoV-2 from the most closely related bat
sequence is estimated to have occurred be-
tween 1948 and 1982 (9). Therefore, the ani-
mal reservoir(s) of SARS-CoV-2 is(are) yet to
be identified.
Similarly to SARS-CoV-1, SARS-CoV-2 binds
to the host angiotensin-converting enzyme 2
(ACE2) receptor. On the basis of ACE2 simi-
larities, a range of different animals have been
used as models. Experimental infections in
dogs (10), cats (10–13), ferrets (10, 14), ham-
sters (15, 16), rhesusmacaques (17), tree shrews
(18), cynomolgus macaques (19), African green
monkeys (20), common marmosets (21), rab-
bits (22), and fruit bats (23) have shown that
these species are susceptible to SARS-CoV-2,
and experimentally infected cats, tree shrews,
hamsters, and ferrets could also transmit the
virus. By contrast, experimental infection of
pigs and several poultry species with SARS-
CoV-2 proved to be unsuccessful (10, 23, 24).
SARS-CoV-2 has also sporadically been identi-
fied in naturally infected animals. In theUnited
States and Hong Kong, SARS-CoV-2 RNA has
been detected in dogs (25). In the Netherlands,
France, Hong Kong, Belgium, Spain, and the
United States, cats have tested positive for
SARS-CoV-2 by reverse transcription polymer-
ase chain reaction (RT-PCR) (26–30). Further-
more, SARS-CoV-2 has been detected in four
tigers and three lions in a zoo in New York
(31). In Italy, the Netherlands, and Wuhan,
China, antibodies to SARS-CoV-2 have been
detected in cats (29, 32, 33). Recently, SARS-
CoV-2 was detected in farmedmink (Neovison
vison), resulting in signs of respiratory disease
and increased mortality (29, 34).
In response to the outbreaks in mink farms,
the Dutch national response system for zoo-
notic diseases was activated. Although the
public health risk of exposure to animals with
SARS-CoV-2 was determined to be low, in-
creased awareness of animals’ possible in-
volvement in the COVID-19 epidemic was
needed. Therefore, from 20May 2020 onward,
mink farmers, veterinarians, and laboratories
were obliged to report symptoms in mink (fam-
ily Mustelidae) to the Netherlands Food and
Consumer Product Safety Authority (NFCPSA),
and an extensive surveillance system was es-
tablished (35).
Whole-genome sequencing (WGS) can be
used to monitor the emergence and spread
of pathogens (36–39). As part of the surveil-
lance effort in the Netherlands, more than
1750 SARS-CoV-2 viruses have been sequenced
to date from patients from different parts of
the country (40). Here, we describe an in-
depth investigation into the SARS-CoV-2 out-
break inmink farms andmink farm employees
in the Netherlands, combining epidemiological
information, surveillance data, andWGS on the
human–animal interface.
SARS-CoV-2 was first diagnosed on two
mink farms (designated NB1 and NB2) in the
Netherlands on 23 and 25 April 2020, respec-
tively. After the initial detection of SARS-CoV-2
on these farms, a thorough investigation was
initiated to identify potential transmission
routes and to perform an environmental and
occupational risk assessment. Here, we de-
scribe the results of the investigation of the
first 16 SARS-CoV-2–affected mink farms by
combining SARS-CoV-2 diagnostics,WGS, and
in-depth interviews.
Owners and employees of the 16mink farms
with SARS-CoV-2–positive animals were in-
cluded in the contact tracing investigation
by the Netherlands Municipal Health Services
and were tested according to national proto-
col. Ninety-seven individuals were tested by
either serological assays and/or RT-PCR. Forty-
three of 88 (49%) upper respiratory tract sam-
ples tested positive by RT-PCR, whereas 38
of 75 (51%) serum samples tested positive for
SARS-CoV-2–specific antibodies. In total, 66
of 97 (68%) tested individuals had evidence
for SARS-CoV-2 infection (Table 1).
During the interview on 28 April, four of
five employees from NB1 reported that they
had experienced respiratory symptoms before
the outbreak was detected in minks, but none
of them had been tested for SARS-CoV-2. Their
symptom-onset dates ranged from 1 April to
9 May. For 16 of themink (sampled on 28 April)
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and one farm employee (sampled on 4May), a
whole-genome sequence was obtained (hCov-
19/Netherlands/NoordBrabant_177/2020).
The human sequence clusters within themink
sequences, although it differs from the closest
mink sequence by 7 nucleotides (nts) (Fig. 1 and
cluster A in Figs. 2 and 3). On farmNB2, SARS-
CoV-2was diagnosed on 25April. Retrospective
analysis showed that one employee from NB2
had been hospitalized with SARS-CoV-2 on
31 March. All samples from the eight employees
taken on 30 April were negative by RT-PCR but
tested positive for SARS-CoV-2 antibodies. The
virus sequence obtained fromNB2 animals was
distinct from that of NB1 animals, indicating a
separate introduction (Figs. 2 and 3, cluster B).
On mink farm NB3, SARS-CoV-2 infection
was diagnosed on 7 May. Initially, all seven em-
ployees tested negative for SARS-CoV-2, but
when retested between 19 and 26 May after
developing COVID-19–related symptoms, five
of seven individuals working or living on the
farm tested positive for SARS-CoV-2 RNA.
Whole-genome sequences were obtained from
these five individuals. The clustering of these
sequences with the sequences derived from
NB3mink, together with initial negative test
results and subsequent symptom onset, indi-
cate that the employees were infected with
SARS-CoV-2 after mink on the farm became
infected. An additional infection was identi-
fied from contact tracing: An individual who
did not visit the farm but had close contact
with one of the employees became infected
with the SARS-CoV-2 strain found on farm
NB3. Animal and human sequences from farm
NB3 were close to those from farm NB1, and
both were categorized in cluster A.
Similarly, on mink farmNB7, zoonotic trans-
mission frommink to humans likely occurred.
On this farm, SARS-CoV-2 infection in mink
was diagnosed on 31 May. NB7 employees
initially tested negative for SARS-CoV-2, but
several of them subsequently began to show
symptoms. Between 10 June and 1 July, sam-
ples were taken from 10 employees, 8 of which
tested positive for SARS-CoV-2 RNA. WGS of
two NB7 employee samples showed that their
virus sequences clustered with the sequences
from the mink at this farm.
The sequences generated from animals and
employees of mink farms were compared
with ~1775 whole-genome sequences in the
national database. To discriminate between
community-acquired and mink farm–related
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individuals (PCR and/or serology)
NB1 23 April 2020 28 April 2020 to 11 May 2020 5/6 (83%) 5/5 (100%) 6/6 (100%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB2 25 April 2020 31 March 2020 to 30 April 2020 1/2 (50%) 7/8 (88%) 7/8 (88%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB3 7 May 2020 11 May 2020 to 26 May 2020 5/7 (71%) 0/6 (0%)* 5/7 (71%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB4 7 May 2020 8 May 2020 1/3 (33%) 2/2 (100%) 2/3 (66%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB5 31 May 2020 1 June 2020 2/7 (29%) 3/6 (50%) 3/7 (43%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB6 31 May 2020 1 June 2020 1/6 (17%) 4/6 (66%) 4/6 (66%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB7 31 May 2020 10 June 2020 to 1 July 2020 8/10 (80%) NA† 8/10 (80%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB8 2 June 2020 3 June 2020 5/10 (50%) 5/9 (56%) 8/10 (80%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB9 4 June 2020 7 June 2020 1/7 (14%) 1/7 (14%) 2/7 (29%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB10 8 June 2020 11 June 2020 1/8 (13%) 3/8 (38%) 4/8 (50%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB11 8 June 2020 11 June 2020 1/3 (33%) 0/2 (0%) 1/3 (33%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB12 9 June 2020 11 June 2020 6/9 (66%) 2/8 (25%) 7/9 (78%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB13 14 June 2020 11 June 2020 to 18 June 2020 3/3 (100%) 0/2 (0%) 3/3 (100%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB14 14 June 2020 14 June 2020 1/3 (33%) 5/6 (83%) 5/6 (83%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB15 21 June 2020 10 June 2020 to 30 June 2020 2/2 (100%) NA† 2/2 (100%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB16 21 June 2020 23 June 2020 0/2 (0%) NA† 0/2 (0%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
Total 43/88 (49%) 37/75 (49%) 66/97 (68%)
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
*Serology was performed ~1 week before the positive PCR test. †No serology was performed (NA, not applicable).
Fig. 1. Phylogenetic analysis of mink farm NB1. A maximum likelihood analysis was performed using
all available SARS-CoV-2 sequences from the Netherlands. Sequences from NB1 are depicted in red, and
the employee of NB1 is shown in bold. The two sequences in black at the root of the cluster are the
closest-matching human genome sequences from the national SARS-CoV-2 sequence database. The scale
bar represents units of substitutions per site.
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infections and to determine the potential risk
for peoplewho live nearmink farms,WGSwas
also performed on34 SARS-CoV-2–positive sam-
ples (collected from4Marchuntil 29April 2020)
from individuals who live in the same geo-
graphic area (as determined by four-digit postal
code) in which farms NB1 to NB4 are located.
These local sequences, sampled in a proxy of
~19 km2, reflected the general diversity of
SARS-CoV-2 seen in theNetherlands andwere
not related to the clusters of mink sequences
found on the mink farms, thereby indicating
that no spillover to people living in close proxi-
mity to mink farms had occurred and that the
sequences from SARS-CoV-2–infected animals
and farm workers clustered by farm (Fig. 2;
sequences from community shown in magen-
ta). The sequences from the mink farm investi-
gation were also compared with sequences
from Poland (n = 65) because many of the
mink farm workers were seasonal migrants
from Poland, but the Polish sequences were
more divergent.
Phylogenetic analysis of themink SARS-CoV-2
genomes showed that mink sequences of
16 farmswere grouped into fivedifferent clusters
(Figs. 2 and 3). Viruses from farms NB1, NB3,
NB4, NB8, NB12, NB13, and NB16 belonged to
cluster A; sequences from NB2 formed a dis-
tinct cluster (cluster B); those from farmsNB6,
NB7, NB9, and NB14 formed cluster C; those
from NB5, NB8, NB10, and NB15 formed clus-
ter D; and those from NB11 were designated
as cluster E. On farmNB8, SARS-CoV-2 viruses
from clusters A and D were found. A detailed
inventory of possible common characteristics—
including farm owner, shared personnel, feed
supplier, and veterinary service provider—was
made. Multiple farms within a cluster shared
the same owner; however, in most cases no
common factor could be identified for most
farms, and clustering could not be explained
by geographic distance (Table 2 and Fig. 4).
In total, 18 sequences from mink farm em-
ployees or their close contacts were generated
from seven different farms. In most cases,
these human sequences were nearly identical
to the mink sequences from the same farm.
For NB1, the situation was different: The hu-
man sequence clusters deeply within the se-
quences derived frommink (Fig. 1), differing
from the closest related mink sequence by
7 nts. This was also the case on farm NB14,
with a 4-nt difference from the closest related
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Fig. 2. Maximum likelihood analysis of all SARS-CoV-2 sequences from the Netherlands. Sequences derived from minks from different farms are indicated
with different colors, human sequences related to the mink farms are shown in blue, and samples from similar areas (as determined by four-digit postal code) are shown in
magenta. The scale bar represents units of substitutions per site.
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mink sequence. Sequences of employees at
mink farm NB8 clustered with those of ani-
mals from NB12, likely because personnel were
exchanged between these two farms.
SARS-CoV-2 was detected on mink farms
NB1 andNB4 after reports of respiratory symp-
toms and increased mortality in mink. The
sequences from farmNB1 showed a difference
of 0 to 9 single-nucleotide polymorphisms
(SNPs) (average of 3.9 nts) and sequences
from NB4 had a difference of 0 to 8 SNPs
(average of 3.6 nts), which is more than is
generally observed in outbreaks in human
settings. In addition, two deletions (one of
12 nts and one of 134 nts) were observed in a
single sequence from NB1. The sequences of
mink at NB6 had differences of 0 to 12 SNPs,
and a deletion of 9 nts was observed in one
sequence, whereas diversity was lower for the
subsequent farm sequences (Table 2). After
the initial detection of SARS-CoV-2, farms
were screened weekly. The first, second, fifth,
and sixth weekly screening yielded new posi-
tive cases.
Several nonsynonymous mutations were id-
entified among the mink sequences when
comparedwith theWuhan reference sequence
NC_045512.2. However, no particular amino
acid substitutionswere found in all-mink sam-
ples (fig. S1). Of note, three clusters had the
position 614G variant (clusters A, C, and E),
and two had the original variant. On the basis
of the data available at this stage, there were
no obvious disease presentation differences in
animals or humans between clusters, but data
collection and analysis are ongoing for cases
after NB16. The mutations we observed can
also be found in the general human popula-
tion, and the same mutations were found in
human cases related to the mink farms.
Our work shows evidence of ongoing SARS-
CoV-2 transmission in mink farms and spill-
over events to humans. More research in
minks andothermustelid specieswill be needed
to determine whether these species are at risk
of becoming reservoirs of SARS-CoV-2. After
the detection of SARS-CoV-2 on mink farms,
68% of the tested farm workers and/or rela-
tives or contacts would later become or had
been infectedwith SARS-CoV-2, indicating that
contact with SARS-CoV-2–infected mink is a
risk factor for contracting COVID-19. Recent-
ly, an eightfold increase in cytidine-to-uridine
(C→U) substitutions compared with uridine-
to-cytidine (U→C) substitutions was described,
suggestive of host adaptation (41). In the mink
sequences, we observed a 3.5-fold increase in
C→U compared with U→C substitutions, but
the number of substitutions (185) was limited.
A high diversity was observed in the se-
quences from some mink farms, which is
likely explained by multiple generations of
viral infections in animals before the increase
in mortality was detected. Current estimates
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Fig. 3. Phylogenetic analysis of 88 mink and 18 mink-related human SARS-CoV-2 sequences detected
in the five mink farm clusters. Sequences derived from different farms are depicted in different colors.
The scale bar represents units of substitutions per site.
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Table 2. Overview of the clusters detected on the different farms. Note that veterinarians II and V were from the same veterinary practice. In regard to
detection, notification was based on reporting of clinical signs, which was required from 26 April onward. EWS-Ser detection was based on a one-time
nationwide compulsory serological screening of all mink farms at the end of May or early June by GD Animal Health. EWS-PM detection was based on the early
warning monitoring system (EWS) for which carcasses of animals that died of natural causes were submitted weekly for PCR testing by GD Animal Health from



















NB1 24 April 2020 A NB1, NB4 1 I 17 (+1) 0 to 9 (3.9) 75,711 Notification
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB2 25 April 2020 B NA 1 II 8 0 to 8 (3.6) 50,473 Notification
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB3 7 May 2020 A NA 2 III 5 (+5) 0 to 2 (0.6) 12,400 Notification
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB4 7 May 2020 A NB1, NB4 1 I 1 NA 67,945 Contact tracing NB1
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB5 31 May 2020 D NA 1 IV 1 NA 38,936 EWS-Ser+PM-1st
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB6 31 May 2020 C NA 3 V 9 0 to 12 (6.8) 54,515 EWS-Ser+PM-1st
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB7 31 May 2020 C NB7, NB11, NB15 3 II 6 (+2) 0 to 4 (1.4) 79,355 EWS-PM-1st
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB8 2 June 2020 A and D NB8, NB12* 3 V 6 (+5) 0 to 6 (2.6) 39,144 EWS-Ser+PM-1st
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB9 4 June 2020 C NA 2 V 2 (+1) 0 to 3 (1.5) 32,557 EWS-Ser+PM-2nd
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB10 8 June 2020 D NA 3 II 4 0 to 3 (1.1) 26,824 EWS-Ser+PM-2nd
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB11 8 June 2020 E NB7, NB11, NB15 3 II 4 0 to 4 (2.2) 38,745 EWS-PM-2nd
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB12 9 June 2020 A NB8, NB12* 3 II 5 0 to 3 (1.2) 55,352 Notification
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB13 14 June 2020 A NA 3 V 5 (+3) 0 to 5 (3.2) 20,366 EWS-PM-5th
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB14 14 June 2020 C NA 3 II 5 (+1) 0 to 7 (3.7) 28,375 EWS-PM-5th
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB15 21 June 2020 D NB7, NB11, NB15 3 II 5 0 to 2 (0.6) 35,928 EWS-PM-6th
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
NB16 21 June 2020 A NA 3 II 5 0 to 4 (1.6) 66,920 EWS-PM-6th
.. .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .. ... ... .. ... .. ... ... .. ... ... .
*There was exchange of personnel in these two locations.
Fig. 4. Geographic overview of mink
farms with SARS-CoV-2–positive
cases per affected municipality. The
proportion of SARS-CoV-2–affected
mink farms over the total number of mink
farms (Central Bureau of Statistics
database, 2019) is indicated for each area.
Symbols for farms with positive cases are
colored by cluster; non-circular shapes
indicate farms with a single owner.
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indicate that the substitution rate of SARS-
CoV-2 is around 1.16 × 10−3 substitutions per
site per year in the human population (42),
which corresponds to around one mutation
per 2 weeks. This could mean that the virus
was already circulating in mink farms for
some time before it was identified. However,
a relatively high sequence diversity was also
observed in farmed mink that tested negative
week before a positive test, hinting toward a
faster evolutionary rate of the virus in the
mink population. Mink farms have large pop-
ulations of animals, living at high density,
which may promote virus transmission. How-
ever, themoment of viral introductionwas not
known, which makes it difficult to draw defi-
nite conclusions about the substitution rate
in mink farms. Our sequencing did not reveal
any systematic mutations that would need
to be assessed for potential phenotypic effects.
The generation interval for SARS-CoV-2 in
humans has been estimated to be around 4 to
5 days (43), but with high-dose exposure in a
farm with a high number and density of ani-
mals, this interval could potentially be shorter.
Further evidence that animals were themost
likely source of human infection was provided
by the clear phylogenetic separation between
mink farm–related human and animal sequen-
ces and sequences from human cases within
the same geographic area (as determined by
four-digit postal code). However, some of the
farm-related humans may have been infected
within their household, not directly frommink.
Spillback into the local community was not
observed in our sequence data.
Thus far, the investigation has failed to id-
entify common factors that might explain
farm-to-farm spread, possibly via temporary
workers who were not included in testing.
Since our observationsweremade, SARS-CoV-2
infections have also been described in mink
farms elsewhere (44–46). Additional research
efforts are needed, as it is imperative that the
fur production and trading sector not become
a reservoir for future spillover of SARS-CoV-2
to humans.
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